CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-29 | Pierce Christopher EVP and Chief of Business Oper | Exercise or conversion | +3,295 | $1.89 | $6K | 7,045 |
| 2021-04-29 | Pierce Christopher EVP and Chief of Business Oper | Sale | −3,295 | $40.29 | $133K | 3,750 |
| 2021-04-29 | Pierce Christopher EVP and Chief of Business Oper | Exercise or conversion · Employee Stock Option (right to buy) | −3,295 | 4,323 | ||
| 2021-04-29 | Morosini Deborah EVP, Chief of Clinical Affairs | Exercise or conversion | +3,223 | $1.89 | $6K | 3,667 |
| 2021-04-29 | Morosini Deborah EVP, Chief of Clinical Affairs | Sale | −3,223 | $40.29 | $130K | 444 |
| 2021-04-29 | Morosini Deborah EVP, Chief of Clinical Affairs | Exercise or conversion · Employee Stock Option (right to buy) | −3,223 | 4,323 | ||
| 2021-04-27 | Mauro David J Chief Medical Officer | Exercise or conversion | +25,000 | $1.89 | $47K | 25,000 |
| 2021-04-27 | Mauro David J Chief Medical Officer | Sale | −7,688 | $34.66 | $266K | 17,312 |
| 2021-04-27 | Mauro David J Chief Medical Officer | Sale | −15,601 | $35.68 | $557K | 1,711 |
| 2021-04-27 | Mauro David J Chief Medical Officer | Sale | −1,711 | $36.11 | $62K | 0 |
| 2021-04-27 | Mauro David J Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −25,000 | 227,610 | ||
| 2021-04-19 | Mauro David J Chief Medical Officer | Exercise or conversion | +25,000 | $1.89 | $47K | 25,000 |
| 2021-04-19 | Mauro David J Chief Medical Officer | Sale | −21,000 | $30.82 | $647K | 4,000 |
| 2021-04-19 | Mauro David J Chief Medical Officer | Sale | −4,000 | $31.27 | $125K | 0 |
| 2021-04-19 | Mauro David J Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −25,000 | 252,610 | ||
| 2021-04-08 | Scherle Peggy Chief Scientific Officer | Grant or award | +4,630 | $1.43 | $7K | 177,550 |
| 2021-04-08 | Scherle Peggy Chief Scientific Officer | Sale | −1,417 | $36.97 | $52K | 176,133 |
| 2021-04-08 | Scherle Peggy Chief Scientific Officer | Sale | −875 | $37.72 | $33K | 175,258 |
| 2021-04-08 | Scherle Peggy Chief Scientific Officer | Sale | −669 | $38.97 | $26K | 174,589 |
| 2021-04-08 | Scherle Peggy Chief Scientific Officer | Sale | −1,669 | $39.57 | $66K | 172,920 |
Page 13 of 19 · 369 trades